Status:
COMPLETED
ALLO-SCT in Elderly Patients With Hematological Disease
Lead Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Collaborating Sponsors:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Conditions:
Hematologic Diseases
Stem Cell Transplant Complications
Eligibility:
All Genders
60+ years
Brief Summary
Retrospective, observational, multicentre, spontaneous, non-interventional study This study will evaluate all consecutive patients older than 60 years who received hematopoietic stem cell transplantat...
Detailed Description
The age of patients' population is increasing every year, as the life expectancy. Thus, the incidence and prevalence of hematological cancers is increasing. In particular, acute leukemias and myelodys...
Eligibility Criteria
Inclusion
- Allogeneic transplantation from 2000 to 2017 (for patients submitted to more than one transplant, only the first transplant will be considered)
- Informed consent
Exclusion
- Absence of informed consent
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2021
Estimated Enrollment :
1996 Patients enrolled
Trial Details
Trial ID
NCT04386928
Start Date
April 1 2019
End Date
March 16 2021
Last Update
August 20 2021
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero-Universitaria Ospedali Riuniti
Ancona, Italy
2
Ospedale Mazzoni
Ascoli Piceno, Italy
3
Policlinico di Bari-Ematologia con trapianti
Bari, Italy
4
Ospedale San Orsola
Bologna, Italy